Skip to main content
. 2007 Dec 28;1(4):395–405. doi: 10.1016/j.molonc.2007.12.003

Table 2.

BRAF mutations in melanoma tumours

Primary melanomas N mut/total N (%) Metastases N mut/total N (%) Materials Sub‐dissection Detection method References
6/9 (67) P No D,G,I Davies et al., 2002
22/35 (63)a F No D,G,I Brose et al., 2002
7/28 (25) 8/13 (62) P Yes D,I Dong et al., 2003
33/77 (43) F No D,I Gorden et al., 2003
4/5 (80) 37/55 (67) P Yes D,I Pollock et al., 2003
7/25 (28) 26/60 (38) F No D,H Alsina et al., 2003
14/25(52) P Yes D,H,I Uribe et al., 2003
2/10 (20) 14/34 (41) P No D,G,I Cruz et al., 2003
41/71 (58) 43/88 (49) P Yes D,F,I Omholt et al., 2003
32/115 P No D,I Maldonado et al., 2003
12/35 (34) P No D,F,I Kumar et al., 2003a
26/38 (68) P No DF,I Kumar et al., 2003b
19/50 (38) P Yes D,F,I Deichmann et al., 2004
8/15 (53) 6/22 (27) F No D,F,I Reifenberger et al., 2004
39/114 (34) 36/86 (42) P Yes D,I Houben et al., 2004
18/59 (31) 39/68 (57) P Yes D,I Shinozaki et al., 2004
25/36 (69) 43/79 (54) F No D,H Goydos et al., 2005
17/37 (46) P Yes D,I Thomas et al., 2004
9/12 (75) P No D,F,I Saldanha et al., 2004
15/51 (29)b 8/18 (44) P Yes D,F,I Akslen et al., 2005
13/52 (25) P No D,G,I Lang and MacKie, 2005
3/27 (11)c P No D,I Curtin et al., 2005
22/37 (60)d
33/58 (57) P Yes D,I Goel et al., 2006
156/294 (53)e F No D,K Edlundh‐Rose et al., 2006
8/15 (53) P Yes D,I Lassacher et al., 2006
17/62 (27) P Yes D,I Poynter et al., 2006
53/97 (55) F No D,G,I Ugurel et al., 2007
Total 393/983 (40) 528/1029 (51)

Materials: F=fresh frozen tissues; P=formalin fixed, paraffin embedded tissues; manual or laser capture sub‐dissection: yes/no=Detection Method: D PCR or RT PCR; E allele specific oligonucleotide hybridization; F SSCP or DGGE; G HPLC/capillary techniques; H RFLP dependent or allele specific amplification; I nucleotide sequencing; K pyrosequencing.

a

Early passage melanoma cell lines.

b

NM only.

c

Continuously sun exposed sites, mainly LMM.

d

Intermittently sun exposed sites, mainly SSM.

e

Including 39 primary melanomas.